N-carbamoyl-5-oxo-2-phenyloxolane-3-carboxamide

Names

[ CAS No. ]:
13390-04-0

[ Name ]:
N-carbamoyl-5-oxo-2-phenyloxolane-3-carboxamide

[Synonym ]:
Urea,(tetrahydro-5-oxo-2-phenyl-3-furoyl)
(5-Oxo-2-phenyltetrahydro-3-furoyl)urea
3-Furancarboxamide,N-(aminocarbonyl)tetrahydro-5-oxo-3-phenyl
N-carbamoyl-5-oxo-2-phenyltetrahydrofuran-3-carboxamide

Chemical & Physical Properties

[ Molecular Formula ]:
C12H12N2O4

[ Molecular Weight ]:
248.23500

[ Exact Mass ]:
248.08000

[ PSA ]:
102.97000

[ LogP ]:
1.83980

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YU2610000
CHEMICAL NAME :
Urea, (tetrahydro-5-oxo-2-phenyl-3-furoyl)-
CAS REGISTRY NUMBER :
13390-04-0
LAST UPDATED :
198608
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C12-H12-N2-O4
MOLECULAR WEIGHT :
248.26
WISWESSER LINE NOTATION :
T5OVTJ DVMVZ ER

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2550 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AITEAT Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.10- 1962- Volume(issue)/page/year: 15,271,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AITEAT Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.10- 1962- Volume(issue)/page/year: 25,819,1977

Related Compounds

  • N-carbamoyl-5-oxo-2-phenyloxolane-2-carboxamide
  • N,N-diethyl-5-oxo-2-phenyloxolane-3-carboxamide
  • 5-oxo-2-phenyloxolane-3-carboxamide
  • ethyl N-[(5-oxo-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidine-6-carbonyl)amino]carbamate
  • propyl N-(5-oxo-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-6-yl)carbamate
  • methyl N-(5-oxo-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-6-yl)carbamate
  • 2-Methyl-4-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyrimidine
  • 1-(prop-2-enoyl)-N-[3-(thiophen-3-yl)propyl]piperidine-4-carboxamide
  • Tert-butyl 4-(1-(4-(1-aminocyclopropyl)phenyl)-2-cyclopropylethyl)piperazine-1-carboxylate
  • N-[(4-{4-[(1H-imidazol-2-yl)methyl]piperidine-1-carbonyl}phenyl)methyl]prop-2-enamide
  • Ethyl 1-(3,6-dichloropyridine-2-amido)cyclopentane-1-carboxylate
  • 3-((Benzyloxy)methyl)-1H-pyrazole
  • 3-[4,6-dichloro-5-(4,4-difluoropiperidin-1-yl)-1H-benzimidazol-2-yl]-3-(4-ethylsulfonylphenyl)propan-1-ol
  • 4,6-dichloro-2-[[4-(cyclopropylmethylsulfonyl)phenyl]methyl]-5-(4,4-difluoropiperidin-1-yl)-1H-benzimidazole
  • N-(2-(pyridin-3-ylmethoxy)phenyl)acetamide
  • 5-chloro-2-fluoro-N-[4-(trifluoromethyl)cyclohexyl]pyridine-3-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.